nach oben

Comparative Clinical Pathology

Erschienen in:

25.01.2017 | Original Article

Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation

verfasst von: Fahimeh Rezazadeh, Fariba Shahbazi, Azadeh Andisheh-Tadbir

Erschienen in: Comparative Clinical Pathology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Oral lichen planus is an inflammatory disorder with T-cell-mediated immunological etiology. The aim of this study was to evaluate the IL-10 in saliva of OLP patients and compare it with healthy people. In this cross-sectional study, 44 patients with oral lichen planus and 44 healthy people were enrolled to the study. Five to 10 ml un-stimulated whole saliva samples were collected in the morning, and concentration of IL-10 was measured using enzyme-linked immunosorbent assay (ELISA). The mean of salivary IL-10 was more in the patient group (0.2 ± 0.92) than the healthy group (0.1 ± 0.04), but there was no significant difference between these groups. No significant relation was found between salivary IL-10 level and type of OLP. The result of present study showed no significant differences in salivary level of IL-10 between OLP and healthy people.

Amer GA, El Refaei AM, El-Balshy AE-LM (2009) A comparison between serum and salivary tumor necrosis factor-alpha in oral lichen planus. Egyptian Journal of Medical Microbiology 18(1):230

Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson JL et al (2000) Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 96(7):2568–2573PubMed

Couper KN, Blount DG, Riley EM (2008) IL-10 the master regulator of immunity to infection. J Immunol 180(9):5771–5777CrossRefPubMed

Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A (2012) Oral lichen planus as a preneoplastic inflammatory model. Biomed Res Int 2012

Ghabanchi J, Fattahi MJ, Mardani M, Tadbir AA, Paydar AA (2009) Polymorphism of tumor protein p53 codon 72 showed no association with oral lichen planus in Shiraz, Iran. J Craniofac Surg 20(6):2168–2170

Ghallab NA, El-Wakeel N, Shaker OG (2011) Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus. Mediat Inflamm 2010

Gholamin M, Moaven O, Memar B, Farshchian M, Naseh H, Malekzadeh R et al (2009) Overexpression and interactions of interleukin-10, transforming growth factor β, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg 33(7):1439–1445CrossRefPubMed

Hamzavi M, Tadbir AA, Rezvani G, Ashraf MJ, Fattahi MJ, Khademi B et al (2013) Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma. Asian Pacific J Cancer Prev 14:1681–1685CrossRef

Ja R, Sciubba J, Jordan R (2008) Oral pathology: clinical pathologic correlation. Mosby Elsevier, St. Louis, p 345

Liu J, Song B, Wang J-L, Li Z-J, Li W-H, Wang Z-H (2011) Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol 17(10):1362–1367CrossRefPubMedPubMedCentral

Neville BW, Chi AC, Damm DD, Allen CM (2015) Oral and maxillofacial pathology: Elsevier Health Sciences, p 201

Regezi JA, Sciubba JJ, Jordan RC (2012) Oral pathology: clinical pathologic correlations: Elsevier Health Sciences, p 512

Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F (2005) A comparison of the pro-inflammatory, NF-κB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114(3):278–283CrossRefPubMed

Teles RP, Likhari V, Socransky SS, Haffajee AD (2009) Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 44(3):411–417CrossRefPubMedPubMedCentral

Thornhill M (2001) Immune mechanisms in oral lichen planus. Acta Odontol Scand 59(3):174–177CrossRefPubMed

Zhang Y, Lin M, Zhang S, Wang Z, Jiang L, Shen J et al (2008) NF-κB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 41(2):144–149CrossRefPubMed

Zhang Y, Liu W, Zhang S, Dan H, Lu R, Wang F et al (2012) Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 35(2):399–404CrossRefPubMed

Titel: Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation
verfasst von: Fahimeh Rezazadeh
Fariba Shahbazi
Azadeh Andisheh-Tadbir
Publikationsdatum: 25.01.2017
Verlag: Springer London
Erschienen in: Comparative Clinical Pathology / Ausgabe 3/2017
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-017-2415-5

Springer Medizin

Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

A comparative study on selected APP, alkaline phosphatase and lactate dehydrogenase activities in buffalo and cow with subclinical mastitis

Immunohistochemical expression of transforming growth factor Beta-1 in canine mammary carcinomas: its relationships with histologic grading, survival rate, and recurrence

The effect of castration on cortisol changes and blood glucose in horses

Glutathione is a novel treatment for cystine stones

A glutamine and glutamate mixture and its effects on the hematological and biochemical biomarkers in dogs

Effects of preanesthetic administration of metamizole on renal function, blood parameters and bone marrow cells in healthy dogs

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie